What is the main business of Lepus?

The main business activity of Lepus focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on July 28, 2010.

Where is the headquarters located?

The headquarters is located at: Henryka Kamieńskiego 51, 30-644 Kraków.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

Is the company profitable?

No, in 2025 the company was not profitable, reporting a net loss of USD 742. For comparison, in 2024 the loss was USD 2,036, meaning the company reduced its loss by 63.7%.

What is the main operating cost?

The largest operating cost category falls under external services. This category amounted to USD 402 in 2025, representing 99% of all operating expenses.

Lepussp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Suspended

Registry date

2010-07-28

Share capital

5,000.00 PLN

Registered address

Henryka Kamieńskiego 51, 30-644 Kraków, Poland

Electronic delivery address

AE:PL-54241-82041-GTABG-25

Financials

Revenue history

Filing timeliness

1 of 6 financial statements was filed late (for 2024, 27 days late).

202515/07/2026
202411/08/2025
202303/07/2024
202213/07/2023
202114/07/2022
202011/10/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Industry

Authorized Representatives

Beata Kmieć – President of the Management Board

Manner of representation

In the event that a one-person management board is appointed, the President of the Management Board is authorised to represent the company in every matter independently. In the event that a multi-member management board is appointed, each member of the management board is authorised to represent the company independently.

Ownership

Owner	Shares	Share value	Stake
Beata Kmiećage 54	100	$1,350.62	100%

Beneficial owners

Person	Rights

Bank accounts

Was a VAT taxpayer from 2011-06-01 to 2025-04-02.

Reason for removal: Art. 96 ust. 9a pkt 1 (business activity suspended for at least 6 consecutive months)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Mercator MedicalS.A.	$80,479,156.20	mercator.pl
Eclipse Boluk-Sobolewskasp. k.	$10,235,697.61	eclipsemedical.pl
Bardomedsp. z o.o.	$2,460,544.65	bardomed.pl
Passimedsp. z o.o.	$1,761,047.56	passimed.pl
Medimessp. z o.o.	$1,317,775.92	medimes.pl
Model MedicalS.A.	$754,014.76	modelmedical.pl
Interforum Pharmasp. z o.o.	$710,214.55	interforumpharma.com
Softmedicasp. z o.o.	$481,553.31	softmedica.com.pl
Eduaidsp. z o.o.	$22,952.22	eduaid.pl
Beyond Medical Aesthetics Polskasp. z o.o.	$13,696.94	bmapolska.pl

Change history

Date	Event
2026-09-24	Business suspended
2026-09-21	Business resumed
2024-09-20	Business suspended
2024-07-15	Address change (Legnicka 5, 31-216, Kraków → Henryka Kamieńskiego 51, 30-644, Kraków)
2015-08-24	PKD change (Removed: 49.41.Z)

FAQ

Last updated: 2026-10-02